| Patents for C07C 323 - Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups (27,160) |
|---|
| 04/26/2001 | WO2000055125A3 N-cyanomethyl amides as protease inhibitors |
| 04/26/2001 | US20010000513 Treatment of multiple sclerosis, atherosclerotic plaque rupture, aortic aneurism, heart failure, restenosis, periodontal disease, corneal ulceration, treatment of burns, decubital ulcers, wound healing, cancer, inflammation |
| 04/26/2001 | US20010000511 Treatment of skin disorders, inflammation, nerve system disorders, cancer |
| 04/26/2001 | CA2387713A1 Intermediates for making a benzofuran or benzothiophene derivative nitrated in position 5 and uses thereof |
| 04/26/2001 | CA2387570A1 Methods of asymmetrically synthesizing enantiomers of casodex, its derivatives and intermediates thereof |
| 04/26/2001 | CA2384240A1 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
| 04/26/2001 | CA2382126A1 Stabilizers and antiozonants for elastomers |
| 04/25/2001 | EP1093453A1 Naaladase inhibitors useful as pharmaceutical compounds and compositions |
| 04/25/2001 | CN1292783A Method for preparing sulfanyl-type endothelin receptor antagonists |
| 04/25/2001 | CN1292779A Halogenated amidino amino acid derivatives useful as nitric oxide synthase inhibitors |
| 04/25/2001 | CN1064957C N-sulphonyl and N-sulphinyl amino acid amides as microbiocides |
| 04/25/2001 | CN1064956C Ortho-substd. benzoyl guanidine, its preparing method, use thereof and medicine contg. same |
| 04/25/2001 | CN1064954C Orthosubstituted benzoylguanidine, preparation of same, pharmaceutical containing same and application of same |
| 04/25/2001 | CN1064952C New substituted 2,2-dimethyl-omega-phenoxyalkanoic acids and esters, process for their preparation and pharmaceutical compositions containing them |
| 04/24/2001 | US6222064 Fluorination with aminosulfur trifluorides |
| 04/24/2001 | US6222036 Reacting 2-thio-4-dimethyoxymethyl-pyrimidine with acetic acid and catalytic amount of concetrated sulfuric acid to produce 2-thiopyrimidine aldehyde |
| 04/24/2001 | US6221898 Anticoagulants |
| 04/24/2001 | US6221865 Inhibitors of protein farnesyltransferase and protein geranylgeranyltransferase. |
| 04/19/2001 | WO2001027098A2 Method for producing cox-2 inhibitors |
| 04/19/2001 | WO2001027084A1 Beta disubstituted metalloprotease inhibitors |
| 04/19/2001 | WO2001026807A1 Supported ferrocene-based catalysts for selective aldehyde hydrogenation |
| 04/19/2001 | US20010000344 N-(2-(R)-amino-3-mercaptopropyl)-L-penicillaminyl-1,2,3,4 -tetrahydro-3(S)-isoquinoline carbonyl methionine methylester cyclic disulfide, for example; administering as antitumor agent or to treat restenosis |
| 04/19/2001 | CA2386485A1 Beta disubstituted metalloprotease inhibitors |
| 04/19/2001 | CA2383653A1 Supported ferrocene-based catalysts for selective aldehyde hydrogenation |
| 04/18/2001 | EP1091953A1 Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| 04/18/2001 | EP1091948A2 Tubulin binding compounds (cobra) |
| 04/18/2001 | EP1091935A2 Method for preparing 2-nitro-5-(phenylthio)-anilines |
| 04/18/2001 | EP1091934A2 Alkyl ketones as potent anti-cancer agents |
| 04/18/2001 | EP0915823B1 Bi-aromatic compounds, pharmaceutical and cosmetic compositions containing same and uses |
| 04/18/2001 | CN1291973A N-sulphonyl and N-sulphinyl phenylglycinamide |
| 04/17/2001 | US6218572 Preparation of N-Z-protected N-methylated amino acids |
| 04/17/2001 | US6218431 Substituted biphenyls |
| 04/17/2001 | US6218389 For therapy and prophylaxis of arthritis, cancer, cardiovascular disorders; skin disorders; ocular disorders; inflammation and gum diseases, multiple sclerosis, cachexia, preventing loosening of prosthetic devices |
| 04/17/2001 | CA2185192C Novel substituted 2,2,-dimethyl-w-phenoxyalcanoic acids and esters; process for preparing the same and pharmaceutical compositions containing them |
| 04/17/2001 | CA2103044C Novel bi-aromatic compounds derived from a salicylic pattern, method of preparation and use in human and veterinary medicine and in cosmetics |
| 04/17/2001 | CA2027765C Mevinic acid derivatives |
| 04/12/2001 | WO2001025193A1 Phenolic compounds and recording materials containing the same |
| 04/12/2001 | WO1999063939A9 Multibinding inhibitors of cyclooxygenase-2 |
| 04/12/2001 | DE19943634A1 Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften Novel dicarboxylic acid derivatives with pharmaceutical properties |
| 04/11/2001 | EP1090914A2 Processes and intermediates for manufacturing retroviral protease inhibiting compounds |
| 04/11/2001 | EP1090912A1 Amino acid derivatives and drugs containing the same as the active ingredient |
| 04/11/2001 | EP1089968A1 Thyroid hormone analogues and methods for their preparation |
| 04/11/2001 | EP1089967A1 Novel compounds useful in pain management |
| 04/11/2001 | EP1089964A1 Hydrazine derivatives |
| 04/11/2001 | EP1089963A1 Hydroxamic acid derivatives as inhibitors of the production of human cd23 and of the tnf release |
| 04/11/2001 | CN1291183A N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl-3-substituted-alkyl, aryl or heteroarylamides) as matrix metallo protein inhibitors |
| 04/11/2001 | CN1290696A Process for producing mercaptoethanol from waste natural gas |
| 04/11/2001 | CN1064348C Halogenated alpha-amino-ketones and alpha-amino-alcohol and its preparing method |
| 04/10/2001 | US6214878 Stilbene compounds comprising an adamantyl group, compositions and methods thereof |
| 04/10/2001 | US6214876 Indene-1-acetamide sPLA2 inhibitors |
| 04/10/2001 | CA2045736C Novel sulfurized acrylic compounds; process for preparing them and theiruse for synthesizing new polymers |
| 04/05/2001 | WO2001023356A1 Substituted n-phenyl-phenoxy nicotinic acid-(thio) amides and their use as herbicides |
| 04/05/2001 | WO2001023351A1 Fluorochemical oligomer and use thereof |
| 04/05/2001 | WO2001023350A1 Thioalkylamine derivatives and process for the preparation thereof |
| 04/05/2001 | WO2001023349A1 Acylsulfonamide derivatives |
| 04/05/2001 | WO2001023347A1 Novel aromatic compounds |
| 04/05/2001 | WO2001023088A1 Catalyst for asymmetric transfer hydrogenation |
| 04/05/2001 | WO2001023082A2 Biomolecular attachment sites on microelectronic arrays |
| 04/05/2001 | WO2000050398A3 Phenyl- and pyridinyl derivatives as neurokinin 1 antagonists |
| 04/05/2001 | DE19946852A1 Substituierte N-Phenyl-phenoxynicotinsäure-(thio)amide Substituted N-phenyl-phenoxynicotinsäure- (thio) amides |
| 04/05/2001 | CA2386622A1 Biomolecular attachment sites on microelectronic arrays |
| 04/04/2001 | EP1088481A2 Fungicides for the control of take-all disease of plants |
| 04/04/2001 | EP1087981A2 Prenyl transferase inhibitors |
| 04/04/2001 | CN1064043C Process for preparing 1,5-benzothiazepine derivative |
| 04/03/2001 | US6211244 Aromatic amines for complexing calcium |
| 04/03/2001 | US6211242 Benzamide derivatives as vasopressin antagonists |
| 04/03/2001 | US6211234 Substituted phenyl compounds |
| 04/03/2001 | US6211212 Drugs with amide and ester groups as enzyme inhibitors |
| 04/03/2001 | US6211211 Anxiolytic, anticonvulsant and antiepileptic agent |
| 04/03/2001 | US6211197 Carboxylic acid or tetrazole derivates; analgesics, antipyretics, and antiinflammatory agents; side effect reduction |
| 04/03/2001 | US6211178 Antiprotozoa agents for coccidioides; cyclization |
| 03/29/2001 | WO2001021584A1 Tyrosine derivatives |
| 03/29/2001 | WO2001021583A1 Hydroxamic acid derivatives, process for the production thereof and drugs containing the same as the active ingredient |
| 03/29/2001 | WO2001021578A1 O-anisamide derivatives |
| 03/29/2001 | WO2001021576A1 Aromatic diamide derivatives or salts thereof, agricultural/horticultural chemicals and method of using the same |
| 03/29/2001 | WO2001021575A1 Anti-inflammatory nitro- and thia- fatty acids |
| 03/29/2001 | WO2001021172A1 Anti-cancer nitro- and thia-fatty acids |
| 03/29/2001 | WO2000069800A3 Process for preparing ketones or aldehydes |
| 03/29/2001 | WO2000059875A3 Novel inhibitors of formation of advanced glycation endproducts (age's) |
| 03/28/2001 | EP1086079A1 Derivatives of hydroxyphenylsulfanylbenzoic and hydroxyphenylsulfanylarylacetic acids |
| 03/28/2001 | EP1086078A1 Neuropeptide y5 receptor antagonists |
| 03/28/2001 | EP1086077A1 Novel antiestrogens, a method for the production thereof, and their pharmaceutical application |
| 03/28/2001 | EP1086070A1 Method for condensing one or more carbonyl compounds on carbocylic aromatic thioethers or ethers in an acid medium |
| 03/28/2001 | EP1086065A4 Combinatorial synthesis of multibinding libraries |
| 03/28/2001 | EP1086065A1 Combinatorial synthesis of multibinding libraries |
| 03/28/2001 | EP1085894A1 Beta 3-adrenergic receptor agonists |
| 03/28/2001 | EP1085893A1 Phosphodiesterase-v modulator drugs and their uses |
| 03/28/2001 | EP1085891A1 Multibinding inhibitors of topoisomerase |
| 03/28/2001 | EP1085889A2 Novel therapeutic agents that modulate endothelin receptors |
| 03/28/2001 | EP1085887A2 Novel angiotensin receptor modulators and their uses |
| 03/28/2001 | EP1085870A2 Multivalent agonists, partial agonists and antagonists of the gaba receptors |
| 03/28/2001 | EP1085868A1 H1-histamine receptor antagonists |
| 03/28/2001 | EP1085861A1 Inhibitors of nitric oxide synthase |
| 03/28/2001 | EP1085847A2 Novel therapeutic agents that modulate estrogen receptors |
| 03/28/2001 | EP1085846A2 Multibinding inhibitors of microsomal triglyceride transferase protein |
| 03/28/2001 | EP1085845A2 Multibinding inhibitors of cyclooxygenase-2 |
| 03/28/2001 | CN1289371A Transfecting compositions sensitive to reducing conditions, pharmaceutical compositions containing them, and their applications |
| 03/28/2001 | CN1289321A Biphenylsulfonyl cyanamides, method for the production thereof and their utilization as a medicament |
| 03/27/2001 | US6207837 Process for producing dibenzo[b,f]thiepine derivatives |
| 03/27/2001 | US6207708 For therapy and prophylaxis of autoimmune and/or inflammatory conditions affecting the joints such as arthritis, and inflammatory bowel disease, cardivascular ischemia, diabetes, congestive heart failure, myocarditis, atherosclerosis, |